FN2 Earnings Intelligence

Genmab A/S earnings overview

Latest Genmab A/S (GMAB) earnings intelligence, including the newest scorecard, market reaction, and transcript analysis.

Next reportGenmab A/S reports Tuesday, Feb 16, 2027 · Before market openConsensus EPS $0.30 · consensus revenue $1.27B
GMAB FY2026 Q3 · Calendar Q4 2026

Genmab A/S

Genmab's 22% nine-month revenue growth and late-stage pipeline progress support a growth case, but delivery depends on regulatory execution, launch readiness and durable treatment benefits.

EPS surprise+55.6%
Market move-4.3%

Get the GMAB recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.